Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Da Jung Kim, Ho Sup Lee, Joon-Ho Moon, Sang Kyun Sohn, Hyeoung Joon Kim, June-Won Cheong, Deog-Yeon Jo, Hawk Kim, Hyewon Lee, Soo-Mee Bang, Won Sik Lee, Yong Park, Mark Hong Lee, Jae Hoon Lee, Sung Hwa Bae, Min Kyoung Kim, The Korean Society of Hematology AML/MDS Working Party
Published May 29, 2017 · Vol. 8, No. 45 · pp. 79414-79424
Soomin Ahn, Roz Brant, Alan Sharpe, Jonathan R. Dry, Darren R. Hodgson, Elaine Kilgour, Kyung Kim, Seung Tae Kim, Se Hoon Park, Won Ki Kang, Kyoung-Mee Kim, Jeeyun Lee
Published May 23, 2017 · Vol. 8, No. 64 · pp. 107492-107499
Andrew J. Tsung, Maheedhara R. Guda, Swapna Asuthkar, Collin M. Labak, Ian J. Purvis, Yining Lu, Neha Jain, Sarah E. Bach, Durbaka V.R. Prasad, Kiran K. Velpula
Published May 16, 2017 · Vol. 8, No. 27 · pp. 44398-44409
